Abstract
Introduction: Benign paroxysmal positional vertigo is one of the common vestibular disorders encountered in ENT clinics with accompanying vertigo. Study to evaluate the additive effects of betahistine on Epley’s manoeuvre in treating posterior BPPV patients.
Material and Methods: Prospective study was conducted on 50 patients of posterior BPPV diagnosed by the Dix Hallpike test. Subjects were divided into Group A which received the Betahistine therapy along with the canalith repositioning technique (Epley’s manoeuvre) and the second group (Group B) which received the Epley’s manoeuvre alone. The patients were assessed at 1 week and 4 weeks by Visual Analogue Scale (VAS), Dizziness Handicap Inventory (DHI) and Short Form 36 (SF-36).
Results: At the end of 4 weeks, 2 patients in group A (E + B) had positive Dix-Hallpike and 23(92%) had negative Dix-Hallpike, while 11 patients in group B (E) had positive Dix-Hallpike and 14 (56%) had negative Dix-Hallpike with P value < 0.001. The Mean baseline (T0) Visual Analogue Scale (VAS) score in group A (E + B) was 8.60 ± 1.080 and in group B (E) was 8.92 ± 0.996. Post-treatment VAS score was significantly lower in both the groups and was significantly lower in group A(E + B) than in group B (E) (0.680 ± 1.930 vs. 3.96 ± 3.587, respectively, p-value < 0.001). The Mean baseline (T0) Dizziness Handicap Inventory (DHI) scores were similar in groups A and B (77.36 ± 9.49 vs. 80.00 ± 8.9, respectively, p = 0.271). After treatment, the DHI values were significantly lower in both groups. Group A had a better DHI score than group B (10.56 ± 17.12 vs. 44.72 ± 27.35, p < 0.001). The mean baseline (T0) Short Form 36 (SF-36) scores were also similar in groups A and B (19.53 ± 6.85 vs. 18.79 ± 5.50, p = 0.823). Post-treatment of 4 weeks, the SF-36 score significantly improved in both the groups and significantly improved in group A than group B (84.27 ± 17.28 vs. 46.53 ± 24.53, p < 0.001).
Conclusion: Betahistine therapy in conjunction with Epley’s manoeuvre leads to better symptom control and is more effective than Epley’s alone in treating BPPV patients.
Similar content being viewed by others
References
Strupp M, Dieterich M, Brandt T (2013) The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int 110:505–515
Molnar A, McGee S (2014) Diagnosing and treating dizziness. Med Clin North Am 98:583–596
Post RE, Dickerson LM (2010) Dizziness: a diagnostic approach. Am Fam Physician 82:361–368
Furman JM, Balaban CD (2015) Vestibular migraine. Ann NY Acad Sci 1343:90–96
Lacour M, van de Heyning PH, Novotny M, Tighilet B (2007) Betahistine in the treatment of Meniere’s disease. Neuropsychiatr Dis Treat 3:429–440
Froehling DA, Bowen JM, Mohr DN, Brey RH, Beatty CW, Wollan PC et al (2000) The canalith repositioning procedure for the treatment of benign paroxysmal positional vertigo: a randomized controlled trial. Mayo Clinic Proceedings. ;75(7): 695–700
Parnes LS, Agrawal SK, Atlas J (2003) Diagnosis and management of benign paroxysmal positional vertigo (BPPV). Can Med Assoc J 169(7):681–693
Bárány E (1920) Diagnose yon krankheitserscheinungen im bereiche des otolithenapparates. Acta Otolaryngol 2(3):434–437
Von Brevern M, Radtke A, Lezius F et al (2007) Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 78(7):710–715
Baloh R (2003) Vestibular neuritis. N Engl J Med 11:1027–1032
Dix MR, Hallpike CS (1952) The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system. Annals of Otology Rhinology & Laryngology 61(4):987–1016
Wolf M, Hertanu T, Novikov I, Kronenberg J (1999) Epley’s manoeuvre for benign paroxysmal positional vertigo: a prospective study. Clin Otolaryngol Allied Sci 24(1):43–46
Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, GomezFin ˜ana M (2005) Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 262:507–511
Korres S, Balatsouras DG, Ferekidis E (2006) Prognosis of patients with benign paroxysmal positional vertigo treated with repositioning maneuvers. J Laryngol Otol 120:528–533
Mira E, Guidetti G, Ghilardi L et al (2003) Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 260:73–77
Dziadziola JK, Laurikainen EL, Rachel JD, Quirk WS (1999) Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg 120:400–405
Della Pepa C, Guidetti G, Eandi M (2006) Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otolaryngol Ital 26:208–215
Kanagalingam J, Hajioff D, Bennett S, Vertigo (2005) BMJ 330:523
Sayin I, Koç RH, Temirbekov D, Gunes S, Cirak M, Yazici ZM (2022 May-Jun) Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial. Braz J Otorhinolaryngol 88(3):421–426
Cavaliere M, Mottola G, Iemma M (2005) Benign paroxysmal positional vertigo: a study of two maneuvers with and without betahistine. Acta Otolaryngol Ital 25:107–112
Kaur J, Shamanna K (2017) Management of Benign Paroxysmal positional Vertigo: a comparative study between Epleys Manouvre and Betahistine. Int Tinnitus J 21(1):30–34
Guneri EA, Kustutan O (2012) The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 146:104–108
Maslovara S, Soldo SB, Puksec M, Balaban B, Penavic IP (2012) Benign paroxysmal positional vertigo (BPPV): influence of pharmacotherapy and rehabilitation therapy on patients’ recovery rate and life quality. NeuroRehabilitation 31(4):435–441
Acar B, Karasen RM, Buran Y Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo (BPPV). BENT.2015;11:117 – 21
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study design, data collection and analysis, manuscript drafting and revision. Final manuscript was read and approved by all the authors.
Corresponding author
Ethics declarations
Conflicts of Interest
The authors have no competing interests to declare that are relevant to the content of this article.
Ethics Approval
The study protocol was approved by local institutional ethic committee of Govt. Medical college and Rajindra Hospital and it was performed in accordance with the Code of Ethics of the World Medical Association according to the declaration of Helsinki of 1975, as revised in 2000
Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Singh, G., Aggarwal, A., Sahni, D. et al. Comparative Effectiveness Research: Betahistine add-on Therapy with Epley’s Manoeuvre Versus Epley’s Manoeuvre Alone in Treating Posterior BPPV Patients. Indian J Otolaryngol Head Neck Surg 75 (Suppl 1), 204–209 (2023). https://doi.org/10.1007/s12070-022-03369-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-022-03369-7